CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Medical Devices (6123)
Devax is a medical device company engaged in the development of a proprietary drug eluting stent system that aims to provide a clinical solution to treat coronary, carotid and peripheral vascular bifurcation lesions.
Company (Acquired)
Phone: 949-461-0450
13700 Alton Parkway
Suite 164
Irvine, 92618
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Devax | $15.2M | Oct 21, 2010 |
| TriReme Medical | $52.5M | Nov 28, 2012 |
| LuMend | $46.9M | Sep 21, 2005 |
| See all 19 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Name | Firm |
|---|---|
| Login to see details | US Venture Partners |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Bifurcation stent and method of positioning in a body lumen | Apr 19, 2007 | Mar 30, 2010 | Patent |
| Noncylindrical stent deployment system for treating vascular bifurcations | Oct 24, 2006 | Mar 30, 2010 | Patent |
Download PDF